Condition

Brain and Central Nervous System Tumors (2)

Recurrent Glioblastoma (1)

Overall Status

Completed (2)

Recruiting (1)

Phase

phase 3 (2)

n/a (1)

Sponsor

Alliance for Clinical Trials in Oncology (1)

Massachusetts General Hospital (1)

Radiation Therapy Oncology Group (1)

Collaborator

National Cancer Institute (NCI) (3)

Canadian Cancer Trials Group (1)

Eastern Cooperative Oncology Group (1)

European Organisation for Research and Treatment Center (EORTC) (1)

NRG Oncology (1)

North Central Cancer Treatment Group (1)

Study Documents

Intervention Type

drug (3)

radiation (2)

device (1)

Funder Type

Other (3)

Study Type

Interventional (3)

ccnu

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent Glioblastoma Trial in Boston (FMISO PET, MRI, Bevacizumab)

Completed

Has Results

Recurrent Glioblastoma

FMISO PET
+3 more

Boston, Massachusetts

Massachusetts General Hospital

Jul 9, 2021

Brain and CNS Tumors Trial in Worldwide (concomitant temozolomide (TMZ), radiotherapy, procarbazine)

Recruiting

Brain and Central Nervous System Tumors

concomitant temozolomide (TMZ)
+5 more

Birmingham, Alabama
+277 more

Mar 22, 2022

Brain and CNS Tumors Trial in United States (BCNU 80mg/m2, TMZ 200mg/m2, radiation therapy)

Completed

Has Results

Brain and Central Nervous System Tumors

BCNU 80mg/m2
+7 more

Mobile, Alabama
+91 more

Aug 28, 2019